Avenue Therapeutics, Inc.
(NASDAQ:ATXI)
$0.68
0.12 (22.30%)
At Close: 4:00 PM
$0.63
-0.05 (-7.35%)
After Market: 3:27 AM
ATXI Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ATXI Stock Price Today
Avenue Therapeutics, Inc. (ATXI) stock rallied over 22.30% intraday to trade at $0.68 a share on NASDAQ. The stock opened with a gain of 2.05% at $0.57 and touched an intraday high of $0.72, rising 22.30% against the last close of $0.56. The Avenue Therapeutics, Inc. in stock market went to a low of $0.56 during the session.
ATXI Stock Snapshot
$0.56
Prev. Close
4.86 Million
Market Cap
$0.56
Day Low
$0.57
Open
N/A
Number of Shares
$0.72
Day High
N/A
P/E ratio
-1.91
EPS (TTM)
0.19
Cash Flow per Share
N/A
Free Float in %
-0.67
Book Value
385857.00
Volume
ATXI Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
1140 Avenue of the AmericaNew York, NY 10036US
Website:https://www.avenuetx.com
Contact #:781 652 4500
Company Information
EmployeesN/A
BetaN/A
Sales or RevenueN/A
5Y Sales Change0.00%
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was incorporated in 2015 and is based in New York, New York.
Peers
Frequently Asked Questions
What is the current Avenue Therapeutics, Inc. (ATXI) stock price?
Avenue Therapeutics, Inc. (NASDAQ: ATXI) stock price is $0.68 in the last trading session. During the trading session, ATXI stock reached the peak price of $0.72 while $0.56 was the lowest point it dropped to. The percentage change in ATXI stock occurred in the recent session was 22.30% while the dollar amount for the price change in ATXI stock was $0.12.
ATXI's industry and sector of operation?
The NASDAQ listed ATXI is part of Biotechnology industry that operates in the broader Healthcare sector. Avenue Therapeutics, Inc. , a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting.
Who are the executives of ATXI?
Srinivas Subramanian
Executive Vice President
Mr. David Jin
Interim Chief Financial Officer, Chief Operating Officer & Corporation Sec.
Dr. Lindsay Allan Rosenwald
Executive Chairman
Dr. Alexandra MacLean M.D.
Chief Executive Officer
How ATXI did perform over past 52-week?
ATXI's closing price is 0.17% higher than its 52-week low of $0.539 where as its distance from 52-week high of $16.65 is -0.94%.
How many employees does ATXI have?
Number of ATXI employees currently stands at N/A. ATXI operates from 1140 Avenue of the America, New York, NY 10036, US.
Link for ATXI official website?
Official Website of ATXI is: https://www.avenuetx.com
How do I contact ATXI?
ATXI could be contacted at phone #781 652 4500 and can also be accessed through its website. ATXI operates from 1140 Avenue of the America, New York, NY 10036, US.
How many shares of ATXI are traded daily?
ATXI stock volume for the day was 385857.00 shares. The average number of ATXI shares traded daily for last 3 months was 65.15 Thousands.
What is the market cap of ATXI currently?
The market value of ATXI currently stands at $4.86 Million with its latest stock price at $0.68 and N/A of its shares outstanding.